Evidence map›Paper›PMID 34912045›Full record

ArticleCommunications biology2021

MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples.

Masachika Ikegami, Shinji Kohsaka, Takeshi Hirose, Toshihide Ueno, Satoshi Inoue, Naoki Kanomata, Hideko Yamauchi, Taisuke Mori, Shigeki Sekine, Yoshihiro Inamoto and 4 more

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Masachika IkegamiDivision of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan. ikegami-tky@umin.ac.jp.ORCID 0000-0003-0491-7142
Shinji KohsakaDivision of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan. skohsaka@ncc.go.jp.ORCID 0000-0001-8651-6136
Takeshi HiroseDivision of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.ORCID 0000-0003-1588-9757
Toshihide UenoDivision of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.ORCID 0000-0002-7408-7298
Satoshi InoueDivision of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan.
Naoki KanomataDepartment of Pathology, St Luke's International Hospital, Tokyo, Japan.
Hideko YamauchiDepartment of Breast Surgical Oncology, St Luke's International Hospital, Tokyo, Japan.
Taisuke MoriDivision of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.
Shigeki SekineDivision of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.
Yoshihiro InamotoDepartment of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan.
Yasushi YatabeDivision of Molecular Pathology, National Cancer Center Research Institute, Tokyo, Japan.ORCID 0000-0003-1788-559X
Hiroshi KobayashiDepartment of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Sakae TanakaDepartment of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.ORCID 0000-0001-9210-9414
Hiroyuki ManoDivision of Cellular Signaling, National Cancer Center Research Institute, Tokyo, Japan. hmano@ncc.go.jp.ORCID 0000-0003-4645-0181
National Cancer Research Institute · GBSt. Luke's International Hospital · JPThe University of Tokyo · JPKyushu University · JPTokyo Metropolitan Komagome Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The clinical sequencing of tumors is usually performed on formalin-fixed, paraffin-embedded samples and results in many sequencing errors. We identified that most of these errors are detected in chimeric reads caused by single-strand DNA molecules with microhomology. During the end-repair step of library preparation, mutations are introduced by the mis-annealing of two single-strand DNA molecules comprising homologous sequences. The mutated bases are distributed unevenly near the ends in the individual reads. Our filtering pipeline, MicroSEC, focuses on the uneven distribution of mutations in each read and removes the sequencing errors in formalin-fixed, paraffin-embedded samples without over-eliminating the mutations detected also in fresh frozen samples. Amplicon-based sequencing using 97 mutations confirmed that the sensitivity and specificity of MicroSEC were 97% (95% confidence interval: 82-100%) and 96% (95% confidence interval: 88-99%), respectively. Our pipeline will increase the reliability of the clinical sequencing and advance the cancer research using formalin-fixed, paraffin-embedded samples.

Indexed as

MutationFiltrationFormaldehydeGene LibraryHumansParaffin EmbeddingReproducibility of ResultsSensitivity and SpecificityFormaldehyde

Identifiers

PMID34912045
PMCPMC8674242
OpenAlexW4200624225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.